New Key Statistics Module, Z-Score and F-Score
SZSE:300966 Key Ratios
Market Cap ¥ M | 1,616.21 |
Enterprise Value ¥ M | 2,422.45 |
P/E(ttm) | 1,402.00 |
PE Ratio without NRI | 222.54 |
Forward PE Ratio | -- |
Price/Book | 1.71 |
Price/Sales | 3.13 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.25 |
Revenue (TTM) ¥ M | 532.00 |
EPS (TTM) ¥ | 0.01 |
Beneish M-Score | -3.24 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -15.10 |
y-y EBITDA Growth Rate % | -76.00 |
EV-to-EBIT | 307.38 |
EV-to-EBITDA | 307.38 |
PEG | -- |
Shares Outstanding M | 115.28 |
Net Margin (%) | 0.08 |
Operating Margin % | 3.56 |
Pre-tax Margin (%) | -1.24 |
Quick Ratio | 0.73 |
Current Ratio | 1.22 |
ROA % (ttm) | 0.02 |
ROE % (ttm) | 0.04 |
ROIC % (ttm) | 0.35 |
Dividend Yield % | 0.11 |
Altman Z-Score | 1.00 |
SZSE:300966 Number of Guru Trades
SZSE:300966 Volume of Guru Trades
Gurus Latest Trades with SZSE:300966
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300966 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Goto Biopharm Co Ltd Insider Transactions
No Available Data